Pérez Martínez A, Martínez Ibáñez V, Ezzedine M
Departamento de cirugía pediátrica, Hospital Infantil Valle de Hebrón, Barcelona.
Cir Pediatr. 1993 Apr;6(2):59-62.
The use of a totally implantable reservoir venous system (RIAV) in children improved the quality of life of a large group of patients undergoing long-term drug therapy. We have routinely used RIAV in the last four years with specific therapeutic indications. One hundred and seven Low Profile model Port-a-Cath (PAC) and two PAS-Port were followed in 104 patients, for a total of 43.000 days, i.e. 395 days per system. Complications which arose in our series were classified as severe (requiring system withdrawal) and slight (resolved medically). There were 17 severe complications: 9 obstructions, 5 infections, 2 skin necrosis and 1 catheter roture, and 5 slight complications including 2 obstructions, 2 system infections and 1 haematoma. Analysis of complications provided the experience necessary to establish a protocol, in order to reduce the number of catheter withdrawals to a minimum.
在儿童中使用完全植入式储液器静脉系统(RIAV)改善了一大批接受长期药物治疗患者的生活质量。在过去四年中,我们根据特定的治疗指征常规使用RIAV。对104例患者的107个低轮廓型植入式静脉输液港(PAC)和2个PAS端口进行了跟踪,共计43000天,即每个系统395天。我们系列中出现的并发症分为严重(需要取出系统)和轻微(通过药物治疗解决)。有17例严重并发症:9例梗阻、5例感染、2例皮肤坏死和1例导管破裂,以及5例轻微并发症,包括2例梗阻、2例系统感染和1例血肿。对并发症的分析提供了制定方案所需的经验,以便将导管取出的次数降至最低。